» Authors » Susan Fox

Susan Fox

Explore the profile of Susan Fox including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 1148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Assaad A, Ding L, Duan Q, Mersha T, Warren C, Bilaver L, et al.
J Allergy Clin Immunol Pract . 2024 Dec; PMID: 39736352
Background: Total serum IgE (TsIgE) has not been examined in children with food allergy. Objective: To evaluate associations of TsIgE with patient, household, environmental, and community-level characteristics among children with...
2.
Tao B, Tsai C, Wang C, Vosoughi A, Bui E, Chapman K, et al.
BMJ Lead . 2024 Nov; PMID: 39532389
Background: Despite efforts to advance equity, diversity and inclusion, women face gender-based barriers in research, including in neurology. Compared with men, women are less likely to hold leadership positions and...
3.
Kalia L, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca D, et al.
Nat Rev Neurol . 2024 Oct; 20(12):724-737. PMID: 39375563
The development of disease-modifying therapies (DMTs) for neurological disorders is an important goal in modern neurology, and the associated challenges are similar in many chronic neurological conditions. Major advances have...
4.
Bannon M, Thivalapill N, Fithian E, Jiang J, Herbert L, Fox S, et al.
Ann Allergy Asthma Immunol . 2024 Aug; 133(5):581-584.e3. PMID: 39179104
Background: Potential racial and ethnic disparities related to oral immunotherapy (OIT) have not been fully described among children with food allergy (FA). Objective: To characterize the differences in attitudes toward,...
5.
Couto B, Di Luca D, Antwi J, Bhakta P, Fox S, Tartaglia M, et al.
Parkinsonism Relat Disord . 2024 Apr; 123:106955. PMID: 38677215
Background: Progressive Supranuclear Palsy (PSP) is a sporadic neurodegenerative disease without a clear geographic prevalence. Cohorts studied in the UK and India showed no higher prevalence of atypical parkinsonism in...
6.
Schweitzer L, Barkati S, Laneuville P, Fox S, Vinh D
J Clin Immunol . 2024 Apr; 44(4):97. PMID: 38587706
No abstract available.
7.
Wyse R, Isaacs T, Barker R, Cookson M, Dawson T, Devos D, et al.
J Parkinsons Dis . 2024 Apr; 14(4):657-666. PMID: 38578902
In 2011, the UK medical research charity Cure Parkinson's set up the international Linked Clinical Trials (iLCT) committee to help expedite the clinical testing of potentially disease modifying therapies for...
8.
Garcia-Cordero I, Anastassiadis C, Khoja A, Morales-Rivero A, Thapa S, Vasilevskaya A, et al.
Ann Neurol . 2024 Apr; 96(1):99-109. PMID: 38578117
Objectives: To evaluate the effect of Alzheimer's disease (AD) -related biomarker change on clinical features, brain atrophy and functional connectivity of patients with corticobasal syndrome (CBS) and progressive supranuclear palsy...
9.
Weerawarna P, Schiefer I, Soares P, Fox S, Morimoto R, Melani R, et al.
ACS Cent Sci . 2024 Jan; 10(1):87-103. PMID: 38292603
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure, and current treatment options are very limited. Previously, we performed a high-throughput screen to identify small molecules that...
10.
Foltynie T, Bruno V, Fox S, Kuhn A, Lindop F, Lees A
Lancet . 2024 Jan; 403(10423):305-324. PMID: 38245250
Although dopamine replacement therapy remains a core component of Parkinson's disease treatment, the onset of motor fluctuations and dyskinetic movements might require a range of medical and surgical approaches from...